Skip to main content

Advertisement

Table 1 Baseline Characteristics of the Original METS Cohort (2506) by Sitea (mean ± SD, %)

From: Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition: the METS-Microbiome study protocol

  Ghana (n = 500) South Africa (n = 504) Jamaica (n = 500) Seychelles (n = 500) USA (n = 502)
Age (y) 34.3 ± 6.7 33.4 ± 5.8 34.4 ± 6.1 36.1 ± 5.6 35.3 ± 6.3
BMI (kg/m2) 24.1 ± 4.6 27.5 ± 8.1 26.5 ± 6.4 27.1 ± 5.7 31.9 ± 8.5
Fat Mass (kg) 18.5 ± 9.2 29.0 ± 16.0 24.7 ± 13.4 25.8 ± 11.1 37.7 ± 18.3
Body Fat (%) 28.3 ± 10.3 36.8 ± 11.4 31.0 ± 11.4 33.1 ± 9.2 39.1 ± 11.0
Plasma Glucose (mg/dL) 99.7 ± 12.1 84.0 ± 23.0 93.1 ± 9.4 100.7 ± 29.1 100.1 ± 34.8
% Carbohydrate (%Energy) 65.8 ± 10.4 54.9 ± 11.8 58.5 ± 8.5 51.2 ± 9.3 45.9 ± 9.4
% Protein (%Energy) 11.9 ± 4.0 16.6 ± 4.8 14.8 ± 4.1 18.4 ± 4.7 15.5 ± 4.1
% Fat (%Energy) 21.7 ± 9.2 26.4 ± 9.3 25.6 ± 6.6 28.4 ± 7.6 36.6 ± 7.0
Fiber (g/day) 25.0 ± 9.7 8.7 ± 4.0 16.5 ± 8.4 13.5 ± 6.7 14.2 ± 7.1
Soluble Fiber (g/day) 6.0 ± 2.8 2.9 ± 1.4 4.9 ± 2.7 3.9 ± 2.1 4.6 ± 2.4
Insoluble Fiber (g/day) 18.9 ± 7.5 5.8 ± 2.9 11.6 ± 6.1 9.6 ± 5.1 9.5 ± 5.38
Obesity (%) 9.8 32.1 27.6 26.4 52.4
Diabetes (%) 1.0 2.4 0.2 3.4 9.6
  1. aSites are presented according to their level of Epidemiologic Transition, using Human Development Index rankings. Diabetes, random glucose > 140 mg/dL or currently taking diabetes medication